We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CRSP market cap is 4.66B. The company's latest EPS is USD -1.9135 and P/E is -30.24.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 100M | 70M | 0 | 201.21M | 504k |
| Operating Income | -51.75M | -76.82M | -111.74M | 89.58M | -115.87M |
| Net Income | -53.07M | -77.74M | -112.15M | 89.35M | -116.59M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 289.59M | 719k | 914.96M | 1.2M | 371.21M |
| Operating Income | 67.31M | -348.06M | 379.53M | -650.5M | -150.72M |
| Net Income | 66.86M | -348.87M | 377.66M | -650.18M | -153.61M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.24B | 2.2B | 2.09B | 2.23B | 2.44B |
| Total Liabilities | 389.47M | 380.99M | 359.04M | 346.77M | 355.08M |
| Total Equity | 1.85B | 1.82B | 1.73B | 1.88B | 2.08B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.07B | 1.83B | 2.75B | 2.24B | 2.23B |
| Total Liabilities | 127.33M | 163.73M | 352.42M | 367.58M | 346.77M |
| Total Equity | 939.43M | 1.66B | 2.4B | 1.88B | 1.88B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 8.8M | -124.45M | -164.3M | -260.38M | 109.75M |
| Investing | 117.83M | 334.75M | 456.1M | 374.65M | -97.8M |
| Financing | 5.4M | 22.17M | 23.73M | 62.66M | 305.93M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 56.68M | -238.37M | 538.97M | -495.74M | -260.38M |
| Investing | 1.33M | -541.17M | -1.04B | -258.66M | 374.65M |
| Financing | 430.98M | 1.02B | 250.95M | 38.59M | 62.66M |
| Market Cap | 4.66B |
| Price to Earnings Ratio | -30.24 |
| Price to Sales Ratio | 12.51 |
| Price to Cash Ratio | 11.93 |
| Price to Book Ratio | 2.47 |
| Dividend Yield | - |
| Shares Outstanding | 80.28M |
| Average Volume (1 week) | 1.2M |
| Average Volume (1 Month) | 1.22M |
| 52 Week Change | -10.27% |
| 52 Week High | 91.10 |
| 52 Week Low | 37.55 |
| Spread (Intraday) | 0.2 (0.34%) |
| Company Name | CRISPR Therapeutics AG |
| Address |
baarerstrasse 14 zug 6300 |
| Website | https://www.crisprtx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
